Market Cap 99.28M
Revenue (ttm) 0.00
Net Income (ttm) -147.27M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 101,200
Avg Vol 258,892
Day's Range N/A - N/A
Shares Out 50.14M
Stochastic %K 82%
Beta 0.74
Analysts Hold
Price Target $1.92

Latest News on HLVX

Frazier Life Sciences Appoints Aditya Kohli to Partner

Apr 17, 2025, 8:00 AM EDT - 7 weeks ago

Frazier Life Sciences Appoints Aditya Kohli to Partner

PHAT


Gold Falls Over 1%; HilleVax Shares Plunge

Jul 8, 2024, 2:31 PM EDT - 11 months ago

Gold Falls Over 1%; HilleVax Shares Plunge